ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Philip J. Stella, MD
CCOP - Michigan Cancer Research Consortium
Study Chair - Timothy J. Hobday, M.D.
Mayo Clinic
Principal Investigator - Tom R. Fitch, M.D.
Mayo Clinic
Principal Investigator - Vivek Roy, MD, FACP
Mayo Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
201 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mobile Infirmary Medical Center
Mobile, Alabama, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Ccop - Colorado Cancer Research Program, Incorporated
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - St. Luke'S Medical Center
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- St. Joseph Hospital
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado, United States
- St. Mary-Corwin Regional Medical Center
Pueblo, Colorado, United States
- North Suburban Medical Center
Thorton, Colorado, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Northside Hospital Cancer Center
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Saint Joseph'S Hospital of Atlanta
Atlanta, Georgia, United States
- Wellstar Cobb Hospital
Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at Dekalb Medical Center
Decatur, Georgia, United States
- Gwinnett Medical Center
Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital
Marietta, Georgia, United States
- Southern Regional Medical Center
Riverdale, Georgia, United States
- Cancer Research Center of Hawaii
Honolula, Hawaii, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Kuakini
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Lusitana
Honolulu, Hawaii, United States
- Queen'S Cancer Institute at Queen'S Medical Center
Honolulu, Hawaii, United States
- St. Francis Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital, Incorporated
Honolulu, Hawaii, United States
- Kapiolani Medical Center at Pali Momi
‘Aiea, Hawaii, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- St. Joseph Medical Center
Bloomington, Illinois, United States
- Graham Hospital
Canton, Illinois, United States
- Memorial Hospital
Carthage, Illinois, United States
- Eureka Community Hospital
Eureka, Illinois, United States
- Galesburg Clinic
Galesburg, Illinois, United States
- Galesburg Cottage Hospital
Galesburg, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2005
- Primary completion
- 31 May 2010
- Completion
- 31 Aug 2010
- Last update posted
- 2 Jun 2011
- Registered enrollment
- 50
- Registry id
- NCT00110084
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.